Table 1 Basic charectersticsbased in different patient groups
ICM | IHD | Control | P value | |
|---|---|---|---|---|
Female(%) | 32.00% | 52.00% | 44.00% | |
Age(y) | 59.9 ± 16.8 | 60.5 ± 8.9 | 52.7 ± 16.1 | ns |
HR (bpm) | 74.11 ± 23.61 | 68.57 ± 10.92 | 74.96 ± 12.65 | ns |
sBP (mmHg) | 118.98 ± 31.49 | 129.96 ± 21.83 | 121.46 ± 12.79 | < 0.05 |
dBP (mmHg) | 67.71 ± 19.23 | 71.26 ± 9.67 | 71.83 ± 12.11 | < 0.01 |
EF(%) | 44.53 ± 18.57 | 64.14 ± 9.27 | 68.30 ± 5.46 | < 0.001 |
AST(U/L) | 20.64 ± 6.92 | 21.79 ± 7.22 | 21.03 ± 6.15 | ns |
ALT(U/L) | 26.81 ± 13.42 | 25.18 ± 16.57 | 19.02 ± 12.82 | ns |
CRE (mg/dL) | 68.58 ± 26.33 | 65.17 ± 12.38 | 58.92 ± 12.98 | < 0.05 |
CHOL (mmol/L) | 3.65 ± 1.44 | 3.87 ± 0.91 | 4.31 ± 1.14 | ns |
TG (mmol/L) | 1.54 ± 0.72 | 1.80 ± 1.14 | 1.42 ± 0.76 | ns |
HDLC (mmol/L) | 0.84 ± 0.25 | 0.95 ± 0.22 | 1.19 ± 0.35 | < 0.001 |
LDLC (mmol/L) | 2.25 ± 1.17 | 2.27 ± 0.77 | 2.50 ± 0.87 | ns |
PROBNP (ng/mL) | 9190.28 ± 7955.63 | 415.15 ± 722.46 | 124.64 ± 115.36 | < 0.001 |
In hospital treatment | ||||
Aspirin(%) | 100.0% | 100.0% | 52.0% | |
clopidogrel(%) | 100.0% | 60.0% | 52.0% | |
Anticoagulants(%) | 20.0% | 4.0% | 0.0% | |
AECI(%) | 68.0% | 52.0% | 12.0% | |
ARB(%) | 20.0% | 28.0% | 8.0% | |
β-blocker(%) | 92.0% | 92.0% | 8.0% | |
Statin(%) | 100.0% | 100.0% | 100.0% | |
nitrate(%) | 60.0% | 52.0% | 4.0% | |
CCB(%) | 12.0% | 20.0% | 20.0% | |
Spironolactone(%) | 80.0% | 0.0% | 0.0% | |
Stent afer angiography(%) | 76.0% | 72.0% | 0.0% | |